Phathom Pharmaceuticals, Inc. (PHAT)

NASDAQ: PHAT · Real-Time Price · USD

10.76

+0.28 (2.67%)

Aug 14, 2025, 2:17 PM - Market open

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Vonoprazan	55.25M	Log In
Vonoprazan Growth	8001.47%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	55.25M	Log In
United States Growth	8001.47%	Log In